• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型哌啶衍生的酰胺类可溶性环氧化物水解酶抑制剂作为脂质代谢调节剂,稳定性有所提高。

Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.

作者信息

Pecic Stevan, Zeki Amir A, Xu Xiaoming, Jin Gina Y, Zhang Shuwei, Kodani Sean, Halim Marlin, Morisseau Christophe, Hammock Bruce D, Deng Shi-Xian

机构信息

Department of Medicine, Columbia University, 650 W 168th Street, BB1029, New York, NY 10032, USA.

University of California, Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Davis, CA 95616, USA.

出版信息

Prostaglandins Other Lipid Mediat. 2018 May;136:90-95. doi: 10.1016/j.prostaglandins.2018.02.004. Epub 2018 Mar 20.

DOI:10.1016/j.prostaglandins.2018.02.004
PMID:29567338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5970965/
Abstract

We have previously identified and reported several potent piperidine-derived amide inhibitors of the human soluble epoxide hydrolase (sEH) enzyme. The inhibition of this enzyme leads to elevated levels of epoxyeicosatrienoic acids (EETs), which are known to possess anti-inflammatory, vasodilatory, and anti-fibrotic effects. Herein, we report the synthesis of 9 analogs of the lead sEH inhibitor and the follow-up structure-activity relationship and liver microsome stability studies. Our findings show that isosteric modifications that lead to significant alterations in the steric and electronic properties at a specific position in the molecule can reduce the efficacy by up to 75-fold. On the other hand, substituting hydrogen with deuterium produces a notable increase (∼30%) in the molecules' half-lives in both rat and human microsomes, while maintaining sEH inhibition potency. These data highlight the utility of isosteric replacement for improving bioavailability, and the newly-synthesized inhibitor structures may thus, serve as a starting point for preclinical development. Our docking study reveals that in the catalytic pocket of sEH, these analogs are in proximity of the key amino acids involved in hydrolysis of EETs.

摘要

我们之前已鉴定并报道了几种有效的源自哌啶的人可溶性环氧化物水解酶(sEH)酰胺抑制剂。抑制这种酶会导致环氧二十碳三烯酸(EETs)水平升高,已知EETs具有抗炎、血管舒张和抗纤维化作用。在此,我们报告先导sEH抑制剂的9种类似物的合成以及后续的构效关系和肝微粒体稳定性研究。我们的研究结果表明,导致分子特定位置的空间和电子性质发生显著改变的等排体修饰可使功效降低多达75倍。另一方面,用氘取代氢会使分子在大鼠和人微粒体中的半衰期显著增加(约30%),同时保持sEH抑制效力。这些数据突出了等排体替代在提高生物利用度方面的效用,因此新合成的抑制剂结构可能作为临床前开发的起点。我们的对接研究表明,在sEH的催化口袋中,这些类似物靠近参与EETs水解的关键氨基酸。

相似文献

1
Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.新型哌啶衍生的酰胺类可溶性环氧化物水解酶抑制剂作为脂质代谢调节剂,稳定性有所提高。
Prostaglandins Other Lipid Mediat. 2018 May;136:90-95. doi: 10.1016/j.prostaglandins.2018.02.004. Epub 2018 Mar 20.
2
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.哌啶衍生的非尿素可溶性环氧水解酶抑制剂的合成及构效关系。
Bioorg Med Chem Lett. 2013 Jan 15;23(2):417-21. doi: 10.1016/j.bmcl.2012.11.084. Epub 2012 Dec 1.
3
Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.通过分子对接和MM-GBSA研究1,3,4-恶二唑衍生物作为基于酰胺的可溶性环氧化物水解酶(sEH)抑制剂的结合模式。
Eur Biophys J. 2017 Jul;46(5):445-459. doi: 10.1007/s00249-016-1188-0. Epub 2016 Dec 7.
4
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.优化哌啶基脲作为可溶性环氧化物水解酶抑制剂。
Bioorg Med Chem Lett. 2010 Jan 15;20(2):571-5. doi: 10.1016/j.bmcl.2009.11.091. Epub 2009 Nov 22.
5
Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.进一步探讨双重可溶性环氧水解酶/脂肪酸酰胺水解酶抑制剂的构效关系。
Bioorg Med Chem. 2021 Dec 1;51:116507. doi: 10.1016/j.bmc.2021.116507. Epub 2021 Nov 11.
6
Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.对脂肪酸酰胺水解酶具有双重活性的可溶性环氧化物水解酶抑制剂的鉴定与优化。
Bioorg Med Chem Lett. 2018 Feb 15;28(4):762-768. doi: 10.1016/j.bmcl.2018.01.003. Epub 2018 Jan 4.
7
Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.3-苯基戊二酸的新型酰胺衍生物作为有效的可溶性环氧化物水解酶抑制剂。
Mol Divers. 2021 Feb;25(1):45-53. doi: 10.1007/s11030-019-10023-y. Epub 2019 Dec 23.
8
Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.金刚烷修饰对可溶性环氧化物水解酶抑制活性、物理性质和代谢稳定性的影响。
Bioorg Chem. 2018 Feb;76:510-527. doi: 10.1016/j.bioorg.2017.12.024. Epub 2017 Dec 30.
9
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.小分子可溶环氧化物水解酶抑制剂在炎症和癌症的多靶点和联合治疗中的应用。
Molecules. 2020 Nov 24;25(23):5488. doi: 10.3390/molecules25235488.
10
Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.评估磺酰脲衍生物作为可溶性环氧化物水解酶 (sEH) 抑制剂的治疗潜力。
Molecules. 2024 Jun 26;29(13):3036. doi: 10.3390/molecules29133036.

引用本文的文献

1
Synthesis and evaluation of isoquinolinyl and pyridinyl-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase to alleviate orofacial hyperalgesia in the rat.基于异喹啉基和吡啶基的脂肪酸酰胺水解酶和可溶性环氧水解酶双重抑制剂的合成与评价,以减轻大鼠口腔面部痛觉过敏
Biochem Biophys Rep. 2025 Apr 10;42:102009. doi: 10.1016/j.bbrep.2025.102009. eCollection 2025 Jun.
2
Structure-activity relationship studies and pharmacological evaluation of 4-phenylthiazoles as dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.4-苯基噻唑作为双溶性环氧化物水解酶/脂肪酸酰胺水解酶抑制剂的构效关系研究及药理学评价
Bioorg Med Chem. 2025 Apr 15;121:118112. doi: 10.1016/j.bmc.2025.118112. Epub 2025 Feb 17.
3
Quinolinyl-based multitarget-directed ligands with soluble epoxide hydrolase and fatty acid amide hydrolase inhibitory activities: Synthetic studies and pharmacological evaluations.具有可溶性环氧化物水解酶和脂肪酸酰胺水解酶抑制活性的喹啉基多靶点导向配体:合成研究与药理学评价。
Heliyon. 2024 Jun 1;10(11):e32262. doi: 10.1016/j.heliyon.2024.e32262. eCollection 2024 Jun 15.
4
Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics.可溶性环氧化物水解酶活性增加与射血分数保留的心力衰竭患者死亡率呈正相关:代谢组学证据
Phenomics. 2022 Oct 27;3(1):34-49. doi: 10.1007/s43657-022-00069-8. eCollection 2023 Feb.
5
Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior.苯并噻唑-苯基类似物作为多靶标配体缓解疼痛而不影响正常行为的结构-活性关系研究。
Prostaglandins Other Lipid Mediat. 2023 Feb;164:106702. doi: 10.1016/j.prostaglandins.2022.106702. Epub 2022 Dec 16.
6
Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.进一步探讨双重可溶性环氧水解酶/脂肪酸酰胺水解酶抑制剂的构效关系。
Bioorg Med Chem. 2021 Dec 1;51:116507. doi: 10.1016/j.bmc.2021.116507. Epub 2021 Nov 11.
7
Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development.可溶性环氧化物水解酶抑制剂 EC1728 代谢的种属差异凸显了药物开发中临床相关筛选机制的重要性。
Molecules. 2021 Aug 19;26(16):5034. doi: 10.3390/molecules26165034.
8
Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine.用于兽医学的可溶性环氧化物水解酶强效抑制剂的筛选。
Front Vet Sci. 2020 Aug 26;7:580. doi: 10.3389/fvets.2020.00580. eCollection 2020.
9
Inhibitory Activity of Quercetin 3--Arabinofuranoside and 2-Oxopomolic Acid Derived from on Soluble Epoxide Hydrolase.槲皮素 3--阿拉伯呋喃糖苷和 2-氧代齐墩果酸对可溶性环氧化物水解酶的抑制活性。
Molecules. 2020 Sep 22;25(18):4352. doi: 10.3390/molecules25184352.
10
Inhibitory Activity of Flavonoids, Chrysoeriol and Luteolin-7--Glucopyranoside, on Soluble Epoxide Hydrolase from Capsicum chinense.辣椒中芫花素和木犀草素-7-O-葡萄糖苷对可溶性环氧化物水解酶的抑制活性。
Biomolecules. 2020 Jan 24;10(2):180. doi: 10.3390/biom10020180.

本文引用的文献

1
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.可溶性环氧化物水解酶作为治疗疼痛、炎症和神经退行性疾病的靶点。
Pharmacol Ther. 2017 Dec;180:62-76. doi: 10.1016/j.pharmthera.2017.06.006. Epub 2017 Jun 19.
2
Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.可溶性环氧化物水解酶抑制剂减轻脂多糖诱导的小鼠急性肺损伤并提高生存率。
Shock. 2017 May;47(5):638-645. doi: 10.1097/SHK.0000000000000767.
3
Parabens inhibit fatty acid amide hydrolase: A potential role in paraben-enhanced 3T3-L1 adipocyte differentiation.对羟基苯甲酸酯抑制脂肪酸酰胺水解酶:对羟基苯甲酸酯增强3T3-L1脂肪细胞分化的潜在作用。
Toxicol Lett. 2016 Nov 16;262:92-99. doi: 10.1016/j.toxlet.2016.09.011. Epub 2016 Sep 19.
4
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?重新研究老的药效团:4-氨基喹啉和四氧化烷是否为潜在的两阶段抗疟药?
J Med Chem. 2016 Jan 14;59(1):264-81. doi: 10.1021/acs.jmedchem.5b01374. Epub 2015 Dec 18.
5
Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.外周脂肪酸酰胺水解酶和可溶性环氧化物水解酶抑制剂具有协同镇痛作用。
Pharmacol Res. 2015 Jul;97:7-15. doi: 10.1016/j.phrs.2015.04.001. Epub 2015 Apr 14.
6
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.药物抑制可溶型环氧化物水解酶可预防梗阻性肾病肾间质纤维化。
Am J Physiol Renal Physiol. 2015 Jan 15;308(2):F131-9. doi: 10.1152/ajprenal.00531.2014. Epub 2014 Nov 5.
7
Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.可溶性环氧化物水解酶抑制剂可减轻小鼠的炎症和气道高反应性。
Am J Respir Cell Mol Biol. 2015 Jan;52(1):46-55. doi: 10.1165/rcmb.2013-0440OC.
8
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.哌啶衍生的非尿素可溶性环氧水解酶抑制剂的合成及构效关系。
Bioorg Med Chem Lett. 2013 Jan 15;23(2):417-21. doi: 10.1016/j.bmcl.2012.11.084. Epub 2012 Dec 1.
9
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors.螺哌啶内酯乙酰辅酶 A 羧化酶抑制剂的合成。
J Org Chem. 2012 Nov 16;77(22):10050-7. doi: 10.1021/jo3014808. Epub 2012 Nov 5.
10
Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.可溶性环氧化物水解酶抑制剂的发现:一个具有多种潜在治疗适应症的靶点。
J Med Chem. 2012 Mar 8;55(5):1789-808. doi: 10.1021/jm201468j. Epub 2012 Jan 17.